Riboflavine and severe lactic acidosis

被引：62

作者：

Luzzati, R ^{[1
]}

De Bravo, P

Di Perri, G

Luzzani, A

Concia, E

机构：

[1] Univ Catholique Louvain, Ind Toxicol & Occupat Med Unit, B-1200 Brussels, Belgium

[2] Univ Parma, Sch Med, Lab Ind Toxicol, Parma, Italy

来源：

LANCET | 1999年 / 353卷 / 9156期

关键词：

D O I：

10.1016/S0140-6736(99)00523-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：901 / 902

页数：2

共 5 条

[1] Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway [J].

Brinkman, K ;

ter Hofstede, HJM ;

Burger, DM ;

Smeitinkt, JAM ;

Koopmans, PP .

AIDS, 1998, 12 (14) :1735-1744

[2] Riboflavin to treat nucleoside analogue-induced lactic acidosis [J].

Fouty, B ;

Frerman, F ;

Reves, R .

LANCET, 1998, 352 (9124) :291-292

[3]

MIZCOCK BA, 1992, CRIT CARE MED, V20, P80

[4] Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: Report of two patients and review of the literature [J].

Sundar, K ;

Suarez, M ;

Banogon, PE ;

Shapiro, JM .

CRITICAL CARE MEDICINE, 1997, 25 (08) :1425-1430

[5] RIBOFLAVIN STATUS DURING PREGNANCY [J].

VIR, SC ;

LOVE, AHG ;

THOMPSON, W .

AMERICAN JOURNAL OF CLINICAL NUTRITION, 1981, 34 (12) :2699-2705

← 1 →